Abstract
The risk assessment and control of N-nitrosamine impurities in medicines is a topic of great concern for patients, regulators, and the pharmaceutical industry. This paper discusses a modeling appro...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
